NFKB1 and gastric cancer: Heparanase activity was reduced in AGS cells treated with 5–25 μM RSV, so it can be concluded that resveratrol reduces heparanase activity in gastric cancer cells, which correlates with increased SOD activity and the inhibition of NF-κB transcriptional activity [5].